Search results
Results from the WOW.Com Content Network
The FDA's advisory said people already taking Zantac, made by Sanofi, or generic forms of the antacid should stop and switch to other heartburn medications that do not contain ranitidine.
[citation needed] Also by then, "a wave of recalls" had taken place. [21] Some of the lawsuits, which by October 2021 included over 100,000 plaintiffs, [5] were filed due to impending statute of limitations laws; estimates of how many people used Zantac have been given as high as 15 million. [citation needed] Facets of the legal rangling included:
NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did ...
Sanofi discontinued the ranitidine formulation of Zantac, and the new formulation, Zantac 360, is made with a different active ingredient. Sanofi to settle 4,000 lawsuits claiming Zantac is linked ...
(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people ...
Ranitidine, previously sold under the brand name Zantac [a] among others, is a medication used to decrease stomach acid production. [12] It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. [12] It can be given by mouth, injection into a muscle, or injection into a vein.
First approved in 1983, Zantac became the world's best selling medicine in 1988 and one of the first-ever drugs to top $1 billion in annual sales. Originally marketed by a forerunner of GSK, it ...
Zantac can refer to either of two different H 2 antagonists used to reduce gastric acid secretion: Ranitidine , prior to its 2020 withdrawal from the market Famotidine , following the withdrawal of ranitidine